Record high revenues and robust comparable store sales pushed up earnings of apparel retailer American Eagle Outfitters (AEO) in the first quarter. The results particularly benefitted from the strong performance of the Aerie lingerie brand, and topped analysts’ forecast.
First-quarter profit climbed 57% to $39.9 million or $0.22 per share from the same period last year. On an adjusted basis, earnings climbed 44% to $0.23 per share and surpassed market views.
Net revenues advanced 8% annually to $822.96 million, driving the bottom line growth. Benefitting from the company’s strong brand equity, comparable store sales advanced 9% during the quarter, supported by a 38% growth in the sales of the Aerie underwear brand. Comparable sales of the American Eagle brand increased 4%.
“We are highly focused on our strategic plan, centered on expanding American Eagle, accelerating Aerie’s growth, elevating the customer experience and delivering strong financial returns,” said American Eagle CEO Jay Schottenstein.
Comparable store sales advanced 9% during the quarter, benefitting from the strong brand equity
In recent years, the popularity of Aerie brand grew significantly resulting in strong market share expansion, giving competitors a run for their money. The other contributors to the impressive first quarter results were the aggressive expansion of the company’s e-commerce platform and the growing demand for its jeans brand.
In the first quarter, American Eagle repurchased 2.3 million of its shares for $45 million and paid dividends of $24 million. During the period, the company opened 4 new stores and closed 2, bringing the total store count to 935.
The Pittsburgh-headquartered company anticipates strong year-on-year growth in its second quarter earnings and is expected to come in the range of $0.27 to $0.29 per share, reflecting an anticipated mid-single digits increase in comparable store sales.
Though American Eagle shares made some notable gains soon after the earnings announcement Thursday, they retreated later paring some of the gains.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on